You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 13, 2025

Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor
Published on: February 16, 2018
Xiaofeng Jin1, Conghui Liu1, Tailin Xu2
1School of Biomedical Engineering, Shenzhen University, Shenzhen, Guangdong, 518060, China.
This review examines how combining artificial intelligence with wearable biosensors can improve personalized healthcare. It explores current technological hurdles, material advancements, and the potential for these smart devices to transform patient monitoring and medical decision-making.
08:06The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022
Area of Science:
Background:
No prior work has fully resolved the complex integration requirements for merging machine learning with physiological monitoring hardware. Prior research has shown that individual patient data remains difficult to capture accurately in real-time settings. That uncertainty drove the need for more sophisticated diagnostic tools capable of continuous health tracking. It was already known that traditional monitoring devices often lack the intelligence to interpret complex biological signals effectively. This gap motivated a deeper look into how advanced computational models might enhance sensor performance. Researchers have long sought to bridge the divide between raw data collection and actionable clinical insights. Current literature often treats hardware and software development as separate, siloed domains of inquiry. This review addresses the pressing need to unify these fields for the advancement of personalized therapeutic strategies.
Purpose Of The Study:
The aim of this review is to summarize the most advanced progress made in the key phases of developing future wearable and implantable diagnostic tools. The authors seek to clarify the current state of the field as it transitions from basic biosensing to complex intelligent systems. This work addresses the specific problem of how to effectively integrate machine learning with physiological monitoring hardware. The researchers are motivated by the goal of achieving highly personalized medical treatments for individual patients. They explore the challenges and opportunities inherent in moving these devices toward widespread clinical implementation. The review provides a detailed examination of the most important parts of these systems, including material innovation and intelligence decision architectures. By synthesizing current knowledge, the authors intend to guide future efforts in the design and optimization of smart medical devices. This study serves as a foundational resource for understanding the trajectory of modern health monitoring technology.
Main Methods:
Review Approach involved a comprehensive synthesis of existing literature regarding the evolution of physiological monitoring hardware. The authors examined advancements spanning from basic biosensing to complex machine learning-integrated systems. This analysis focused on identifying the most critical phases required for the successful deployment of future medical devices. The investigators evaluated material science breakthroughs alongside developments in biorecognition and signal processing. They categorized findings based on their contribution to the intelligence decision system architecture. The study utilized a structured framework to compare various approaches to data acquisition and transmission. This systematic evaluation highlighted the current state of the field while pinpointing major technical hurdles. The authors synthesized evidence from diverse sources to provide a holistic view of the current landscape.
Main Results:
Key Findings From the Literature indicate that the convergence of machine learning and sensor hardware is currently moving from theoretical concepts to practical implementation. The authors report that material innovation is the most significant factor for enhancing the sensitivity of future diagnostic tools. They observe that the integration of big data analytics is transforming how health information is interpreted for individual patients. The review identifies signal acquisition and transportation as primary bottlenecks that currently limit device performance. The authors note that the development of intelligent decision systems is essential for translating raw biological data into meaningful clinical outcomes. They highlight that current challenges include balancing power consumption with the need for high-speed data processing. The literature suggests that the transition to implantable technology requires overcoming significant hurdles in biocompatibility and long-term signal stability. The authors conclude that these advancements are creating new opportunities for more tailored and precise medical interventions.
Conclusions:
Synthesis and Implications suggest that material innovation remains a primary driver for improving the sensitivity of next-generation diagnostic platforms. The authors propose that refining biorecognition elements will allow for more precise detection of biomarkers in diverse physiological environments. Future development must prioritize the seamless integration of signal acquisition with intelligent decision-making architectures to ensure reliable performance. The review highlights that overcoming current data processing limitations is necessary for the widespread adoption of these smart medical devices. Authors indicate that the transition from concept to clinical implementation requires addressing significant hurdles in hardware stability and data security. The findings imply that future wearable technology will rely heavily on the synergy between advanced sensing materials and robust computational algorithms. The authors conclude that these devices hold great potential for transforming how clinicians approach individual patient care through continuous monitoring. This synthesis underscores the necessity of interdisciplinary collaboration to move these technologies toward practical, real-world medical applications.
The researchers propose that combining machine learning with physiological hardware enables superior data collection. This integration allows for more accurate health tracking compared to traditional, non-intelligent monitoring devices, which often struggle to interpret complex biological signals effectively.
The authors identify material innovation as a primary component for device advancement. They contrast this with biorecognition elements, noting that both are required to improve the sensitivity of sensors when detecting specific biomarkers in human subjects.
The authors suggest that signal acquisition and transportation are necessary to ensure reliable data flow. They argue that without stable transmission, the intelligent decision system cannot accurately process the physiological information collected from the wearer.
The authors describe data processing as the bridge between raw input and clinical insight. They contrast this with the role of the intelligence decision system, which translates processed information into actionable medical recommendations for the patient.
The researchers measure the success of these devices by their ability to monitor health, fitness, and environmental surroundings. They compare this to the limitations of earlier sensors, which lacked the capacity to integrate such diverse data streams simultaneously.
The authors propose that these devices will eventually enable highly personalized medical treatments. They contrast this future state with current standard practices, which often rely on generalized protocols rather than individual patient data.